NLA Resources
ApoC3 inhibitors
6 Resources
Knowledge Center
The National Lipid Association is your destination for the science of lipid medicine. Now, everything we know is in one place.
ApoC3 inhibitors
6 Available Resources
Episode 2: From Innovation to Impact: The RNA Interference Era Begins
Dr. Bruce Given shares insights into Arrowhead Pharmaceuticals’ innovative approach to siRNA therapeutics and the company’s growing role in lipid…
BALANCE: New Triglyceride-Lowering Drugs
Practical Pearls – TG-Targets ApoC3 & ANGPTL3
Practical Pearls – PALISADE Trial and Plozasiran, a new triglyceride-lowering drug
S5E2: Palisade Phase 3 Data
Alan Brown, MD, FACC, MNLA talks with Robert A. Hegele MD, FRCP about the Palisade Phase 3 Data.
Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology
Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society…
Join the NLA
Become A Member
When you become a member of the NLA, you become part of a collegial multidisciplinary group of leaders dedicated to improving lipid and cardiometabolic health.
